Brief: SynAct Pharma Prepares Move To Nasdaq Stockholm

SynAct Pharma AB

05/02/2021 08:59

Feb 5 (Reuters) - SynAct Pharma AB  SYNACT.TE :  
    * SAID ON THURSDAY HAS DECIDED TO EVALUATE THE CONDITIONS
AND
BEGIN PREPARING FOR LISTING THE COMPANY'S SHARE ON NASDAQ
STOCKHOLM'S MAIN MARKET
    * THE AMBITION IS TO COMPLETE THE LIST CHANGE DURING THE
LAST
QUARTER OF 2021

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkrDhpb9
    
 Further company coverage:  SYNACT.TE  
   
    
    

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600))